Topic: Human Gene Patents

JD Supra Corporate Brief: Drug Pricing in China, Corruption in Brazil, Climate Change in Congress, Antitrust Law in Europe

A Friday in July and you’re reading the JD Supra Corporate Brief? Does it get any better? China is questioning 60 pharmaceutical companies about their drug pricing (Dechert) Myriad is going on the litigation offensive to protect its BRCA1 and BRCA2 patents (MBHB) Even the ITC is targeting patent trolls… (Duane Morris) Companies operating in… Read more »

Inevitable? Supreme Court Myriad Ruling Leads to Challenge of Human Stem Cell Patent

When the Supreme Court ruled last month that human genes were not patent eligible, writes attorney Antoinette Konski of Foley & Lardner: “[m]any in the biotech community were relieved that the Supreme Court in Myriad limited its holding of patent-ineligibility to isolated, naturally-occurring genes. However, patent practitioners cautioned that Myriad’s holding could potentially be applied… Read more »

Attorney: Myriad Decision Shows SCOTUS Striking Necessary Patent Law Balance

“You know you’re living in the end of days when both the ACLU and the Wall Street Journal praise the same Supreme Court decision…” – Gideon Schor Here’s an interesting perspective on yesterday’s Supreme Court decision in AMP v. Myriad from Gideon Schor, litigation partner at Wilson Sonsini Goodrich & Rosati [bold ours]: “…The Court… Read more »

Latest IP Need to Know: Patent Eligibility, Nutella, Texas Trade Secrets Act, Trademark Scams, More

What’s new in intellectual property law? Plenty: patent eligibility of computer-related inventions, a uniform trade secrets act in Texas, new discovery rules for 337 investigations, trademark scams, and a whole lot more. Even Lady Gaga… First, our featured update: a sweet love story with an important message for those who might consider a trademark infringement… Read more »